Patient adherence to medications for common skin conditions has been extensively studied over the past two decades. and suboptimal adherence is a primary contributor to treatment failure. The impact of sub-par adherence in cutaneous T-cell lymphoma (CTCL) patients has been largely unexplored. and promoting adherence in this patient population may represent a promising area of consider... https://www.lorenametaute.com/